ClinicalTrials.gg
Not yet recruitingNCT06542367Updated Aug 13, 2024

Trans Canal Tympanoplasty With Local Anesthesia Using Fat Graft and "TachoSil"

An interventional study of Tympanoplasty performed under local anesthesia using fat graft and "Tachosil". in Tympanic Membrane Perforation, sponsored by HaEmek Medical Center, Israel. Not yet recruiting. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2024-08-13.

Sponsored by HaEmek Medical Center, Israel · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Mar 2026, 8 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
18 Years to 99 Years
Sex
All
01

Study summary

Eligible participants with chronic tympanic membrane perforation (>6 month) will be given a detailed description and offered to participate in the study.

the study investigates the efficacy of trans canal tympanoplasty with local anesthesia using fat pad and "Tachosil". Participants will be followed for 1 year after the procedure with otological examination and successive hearing evaluations.

02

Conditions studied

  • Tympanic Membrane Perforation

Keywords

  • Tympanoplasty
03

In context

Tympanic Membrane Perforation

53 studies on the registry are indexed under Tympanic Membrane Perforation; 14 are open to participants now.

This study's planned enrollment of 20 is below the median of 57 across 39 interventional studies indexed under Tympanic Membrane Perforation.

Browse Tympanic Membrane Perforation studies →

Lead sponsor

HaEmek Medical Center, Israel is the lead sponsor of 237 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Chronic tympanic membrane perforation (>6 months).
  • Central tympanic membrane perforation.
  • Air bone gar of 35 dB or lower at the operated ear.
  • No active otorrhea in the operated ear in the preceding 3 month prior to the procedure.
  • No evidence of a retraction pocket and no suspicion for a cholesteatoma.

Exclusion criteria

Exclusion Criteria:

  • Known ossicular chain dysfunction
  • The tympanic membrane perforation edges are not accessible/visualized transcanal
  • Pregnancy
  • Allergy to lidocaine
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Transcanal tympanoplasty under local anasthesia with fat graft and "Tachosil"

    eligibale participatns with chronic tympanic membrane perforation will be offered to participate. Under local anesthesia, subcutaneous fat from the neck will be harvested. After that trimming of the perforation edges, planting the fat graft medial to the tympanic membrane and placement of the "Tachosil" on top of the fat graft. gelfoam is placed lateral to the tympanic membrane fo fill the ear canal. follow-up will be held at 2, 4-6 and 12 month following the procedure, with audiometric and otological evaluation

    Procedure: Tympanoplasty performed under local anesthesia using fat graft and "Tachosil".

Interventions

  • ProcedureTympanoplasty performed under local anesthesia using fat graft and "Tachosil".

    Under local anesthesia, subcutaneous fat from the neck will be harvested. After that trimming of the perforation edges, planting the fat graft medial to the tympanic membrane and placement of the "Tachosil" on top of the fat graft. gelfoam is placed lateral to the tympanic membrane to fill the ear canal. follow-up will be held at 2, 4-6 and 12 months following the procedure, with audiometric and otological evaluation

06

What researchers measure

Primary outcomes

  1. closure of tympanic membrane perforation

    the effectiveness of the tympanoplasty using far graft and "Tachosil" will be evaluated - whether close of tympanic membrane perforation occured.

    Time frame: 1 year following the procedure

Secondary outcomes

  1. Hearing results following tympanoplasty - Speech recognition threshold

    SRT (Speech recognition threshold) in dB (Decibel) will be evaluated pre and post tympanoplasty using an audiogram.

    Time frame: 1 year following the procedure

  2. Hearing results following tympanoplasty - Pure Tone Average

    PTA air and PTA bone (Pure Tone Average) in dB (Decibel) will be evaluated pre and post tympanoplasty using an audiogram.

    Time frame: 1 year following the procedure

  3. Hearing results following tympanoplasty - air bone gap.

    Air-bone gap in dB (Decibel) will be evaluated pre and post tympanoplasty using an audiogram.

    Time frame: 1 year following the procedure

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 13, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06542367
Responsible party
Yoni Evgeni Gutkovich (Doctor, HaEmek Medical Center, Israel) — Principal investigator
First posted
Aug 7, 2024
Start date
Sep 1, 2024 (estimated)
Primary completion
Mar 1, 2026 (estimated)
Completion
Sep 1, 2026 (estimated)
Last update
Aug 13, 2024

Study contacts

yoni Evgeni Gutkovich, M.D/Ph.D
Contact
yonigo@clalit.org.il
+972-46495563
Lev Shlizerman, M.D
Contact
lev_sh@clalit.org.il
+972-46495563

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion